<?xml version="1.0" encoding="UTF-8"?>
<p>The history of the use of PI dates back to the beginnings of the twentieth century, where the technique has been used without the knowledge of modern immunology. Different analyses from the Spanish flu pandemic confirmed that PI had been implemented, and patients who received a serum had lower mortality than others [
 <xref rid="ref013" ref-type="bibr">13</xref>]. Successful experimental usage of PI in epidemics was carried out during the Ebola virus (EBO) outbreak in 1995 in Kikwit, the Democratic Republic of Congo. Eight patients were transfused with blood donated by five convalescent patients. The mortality rate was significantly lower (12.5%) than the case fatality rate (80%) in Kikwit and other cities [
 <xref rid="ref015" ref-type="bibr">15</xref>]. Evaluation of the safety and efficacy of CP for the treatment of the Ebola virus disease (EVD) was carried out in Guinea. Results revealed that treatment with CP was acceptable to donors, patients, family, and health care providers in the middle of an EVD outbreak with no serious adverse reactions associated with the transfusion of CP [
 <xref rid="ref006" ref-type="bibr">6</xref>].
</p>
